President Donald Trump’s tweet Monday announcing former pharmaceutical executive Alex Azar as his choice to lead the Department of Health and Human Services boasted that Azar “will be a star for better healthcare and lower drug prices!”

But Azar, who led drugmaker Eli Lilly and Co.’s United States operations from 2012 until earlier this year, has contributed significantly to the pharmaceutical industry political spending that the president has decried.

When Trump spoke about the high price of prescription drugs at a White House press conference in October, he spoke of how drug companies “contribute massive amounts of money to political people.”

Overall, since 2000, Azar has spent at least $105,000 on political contributions, according to Federal Election Commission records.

More than $40,000 of that total went to Indianapolis-based Eli Lilly’s political action committee, FEC records show. Outside of the PAC contributions, Azar donated exclusively to Republican candidates, including $5,400 in 2016 to the Trump campaign and affiliated entities.